Project Grant HT94252510903
- This federal Project Grant award, valued at $538,998.00 and provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), aims to enhance the antitumor myeloid immune response for the treatment of adrenocortical carcinoma. The award was made to the University of Utah's Office of Sponsored Projects Division, a major recipient of federal funding that conducts cutting-edge biomedical research. The funding will support a research project focused...
- The University of Utah has been awarded a $1,128,787 Project Grant by the Defense Health Agency, an agency of the U.S. Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The grant is for a 3-year project titled "OPTIMIZING QUANTITATIVE PHASE IMAGING FOR PREDICTING BREAST CANCER THERAPY RESPONSE," with a performance period from January 15, 2024 to January 14, 2027. The funded research aims to develop and evaluate advanced quantitative phase...
- The University of Utah has been awarded a $1,232,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETING IRON-SULFUR CLUSTER ASSEMBLY A NOVEL VULNERABILITY IN KIDNEY CANCER," will fund research focused on developing new treatment approaches for kidney cancer. The award period runs from July 1, 2024, through June 30, 2028. This federal grant program supports a range of biomedical...
- This federal Project Grant award of $369,872 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Utah. The funding supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research, titled "Temporal Coding of the Human Auditory Nerve," will be conducted from September 1, 2025 through August 31, 2027 at the University of...
- This federal Project Grant award, totaling $3,602,532.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports the development of a sustained-release drug delivery device to manage biofilm implant-related infections in the spine and lateral femur. The primary awardee is the University of Utah, which has a strong track record of executing complex medical research projects for federal agencies. The...
- The University of Utah has been awarded a $824,512 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from June 1, 2024 to May 31, 2027, will fund research on "Digital Pathology Predictions of Treatment Response in Hormone-Sensitive Prostate Cancer." This project aims to leverage digital pathology techniques to improve the prediction of treatment outcomes for patients with hormone-sensitive...
- This federal Project Grant award of $462,000.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, will support the University of Utah's research project titled "ADVANCING RISK PREDICTION AND PREVENTION TO MITIGATE THE BURDEN OF CARDIOVASCULAR DISEASE IN MEN WITH PROSTATE CANCER." The award, with a performance period from Sep 15, 2024 to Sep 14, 2026, will fund advanced biomedical research initiatives...
- This $746,410 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to the University of Utah supports research to investigate "Tissue Softening as a Biomarker of Traumatic Brain Injury." The award, effective from August 15, 2024 to August 14, 2027, will enable the university to conduct cutting-edge biomedical research aimed at developing improved diagnostic and treatment approaches for traumatic brain injury, a critical health...
- This Project Grant award of $1,539,469.00 from the Defense Health Agency was provided to the University of Utah under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "Molecular Crosstalk Between Estrogens and Progestogens in Endometrial Cancer." The award will fund this biomedical research project from September 1, 2023 to August 31, 2026. The University of Utah has an extensive track record of collaborating with government agencies on...
- The University of Utah has been awarded a $654,105 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Digital Pathology Predictions of Treatment Response in Hormone-Sensitive Prostate Cancer." The three-year grant, awarded on June 1, 2024, will support the university's cutting-edge research aimed at improving health outcomes for military service members, veterans, and the broader public. The...
This federal Project Grant award of $807,333.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the "SENTRY: STABILITY-ENHANCED TRANSCRIPTOMICS FOR EARLY LUNG CANCER DETECTION" research initiative at the University of Utah. The funding will be used to conduct advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, which runs from August 15, 2025 to August 14, 2028, focuses on developing innovative medical solutions to address critical health challenges relevant to military personnel and civilian populations. The University of Utah, a prominent public research institution, will leverage its extensive expertise in federal contract and grant research across multiple scientific and technological domains to execute this project.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $807.3k | 7/31/25 |